ArticleCell death & disease2017

Identification of 11(13)-dehydroivaxillin as a potent therapeutic agent against non-Hodgkin's lymphoma.

Xinhua Xiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.